首页> 美国卫生研究院文献>International Journal of Molecular Medicine >Comprehensive analysis of drugs to treat SARS-CoV-2 infection: Mechanistic insights into current COVID-19 therapies (Review)
【2h】

Comprehensive analysis of drugs to treat SARS-CoV-2 infection: Mechanistic insights into current COVID-19 therapies (Review)

机译:对治疗SARS-CoV-2感染的药物的综合分析:对当前COVID-19治疗的机理性见解(综述)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The major impact produced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) focused many researchers attention to find treatments that can suppress transmission or ameliorate the disease. Despite the very fast and large flow of scientific data on possible treatment solutions, none have yet demonstrated unequivocal clinical utility against coronavirus disease 2019 (COVID-19). This work represents an exhaustive and critical review of all available data on potential treatments for COVID-19, highlighting their mechanistic characteristics and the strategy development rationale. Drug repurposing, also known as drug repositioning, and target based methods are the most used strategies to advance therapeutic solutions into clinical practice. Current , and evidence regarding proposed treatments are summarized providing strong support for future research efforts.
机译:严重急性呼吸系统综合症冠状病毒2(SARS-CoV-2)产生的主要影响吸引了许多研究人员的注意力,以寻找可以抑制传播或改善疾病的治疗方法。尽管关于可能的治疗方案的科学数据流量非常快且数量巨大,但尚无一例能明确证明其对2019年冠状病毒疾病(COVID-19)的临床实用性。这项工作代表了对COVID-19潜在治疗方法的所有可用数据的详尽而严格的审查,强调了其机理特征和策略制定的原理。药物重定位(也称为药物重定位)和基于目标的方法是将治疗解决方案推向临床实践的最常用策略。总结了有关提议的治疗方法的当前和证据,为将来的研究工作提供了有力的支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号